Arne Schreiber

Papers

Total Citations

H-Index

About

Arne Schreiber is a leading figure in radiation oncology, with a focused expertise in stereotactic body radiation therapy (SBRT) for prostate cancer. His work has been instrumental in advancing hypo-fractionated treatment protocols, which deliver higher doses of radiation in fewer sessions, significantly reducing patient burden. His most-cited study, a German bi-center feasibility trial (2017), demonstrated the safety and efficacy of this approach, paving the way for shorter, more convenient treatment regimens. With 16 citations, this work has influenced clinical practice by challenging conventional fractionation schedules. Schreiber’s contributions are notable for their direct impact on patient care—offering a non-invasive, time-efficient alternative to traditional radiotherapy. His research continues to shape the landscape of prostate cancer treatment, emphasizing minimal side effects without compromising oncological outcomes. For students and researchers, Schreiber’s work exemplifies how translational research can bridge clinical innovation and practical application, making him a key voice in the evolution of modern radiation therapy.